213 related articles for article (PubMed ID: 35862288)
1. A meta-analysis on randomized controlled trials of treating eosinophilic esophagitis with budesonide.
Liu X; Xiao X; Liu D; Tan C
Ann Med; 2022 Dec; 54(1):2078-2088. PubMed ID: 35862288
[TBL] [Abstract][Full Text] [Related]
2. Topical steroids in eosinophilic esophagitis: Systematic review and meta-analysis of placebo-controlled randomized clinical trials.
Murali AR; Gupta A; Attar BM; Ravi V; Koduru P
J Gastroenterol Hepatol; 2016 Jun; 31(6):1111-9. PubMed ID: 26699695
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Budesonide in the Treatment of Eosinophilic Esophagitis: Updated Systematic Review and Meta-Analysis of Randomized and Non-Randomized Studies.
Rawla P; Sunkara T; Thandra KC; Gaduputi V
Drugs R D; 2018 Dec; 18(4):259-269. PubMed ID: 30387081
[TBL] [Abstract][Full Text] [Related]
4. Histologic and Clinical Effects of Different Topical Corticosteroids for Eosinophilic Esophagitis: Lessons from an Updated Meta-Analysis of Placebo-Controlled Randomized Trials.
de Heer J; Miehlke S; Rösch T; Morgner A; Werner Y; Ehlken H; Becher H; Aigner A
Digestion; 2021; 102(3):377-385. PubMed ID: 32610332
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of oral budesonide suspension in pediatric patients with eosinophilic esophagitis.
Gupta SK; Vitanza JM; Collins MH
Clin Gastroenterol Hepatol; 2015 Jan; 13(1):66-76.e3. PubMed ID: 24907502
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Pharmacologic Therapy for Eosinophilic Esophagitis: A Systematic Review and Network Meta-Analysis.
Tomizawa Y; Melek J; Komaki Y; Kavitt RT; Sakuraba A
J Clin Gastroenterol; 2018 Aug; 52(7):596-606. PubMed ID: 28787360
[TBL] [Abstract][Full Text] [Related]
7. Peripheral blood eosinophils and other non-invasive biomarkers can monitor treatment response in eosinophilic oesophagitis.
Schlag C; Miehlke S; Heiseke A; Brockow K; Krug A; von Arnim U; Straumann A; Vieth M; Bussmann C; Mueller R; Greinwald R; Bajbouj M
Aliment Pharmacol Ther; 2015 Nov; 42(9):1122-30. PubMed ID: 26314389
[TBL] [Abstract][Full Text] [Related]
8. Eosinophilic esophagitis--treatment of eosinophilic esophagitis with drugs: corticosteroids.
von Arnim U; Malfertheiner P
Dig Dis; 2014; 32(1-2):126-9. PubMed ID: 24603395
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled Trial.
Lucendo AJ; Miehlke S; Schlag C; Vieth M; von Arnim U; Molina-Infante J; Hartmann D; Bredenoord AJ; Ciriza de Los Rios C; Schubert S; Brückner S; Madisch A; Hayat J; Tack J; Attwood S; Mueller R; Greinwald R; Schoepfer A; Straumann A;
Gastroenterology; 2019 Jul; 157(1):74-86.e15. PubMed ID: 30922997
[TBL] [Abstract][Full Text] [Related]
10. Oral budesonide for induction of remission in ulcerative colitis.
Sherlock ME; MacDonald JK; Griffiths AM; Steinhart AH; Seow CH
Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD007698. PubMed ID: 26497719
[TBL] [Abstract][Full Text] [Related]
11. A Network Meta-Analysis of Randomized Controlled Trials on the Treatment of Eosinophilic Esophagitis in Adults and Children.
Rokkas T; Niv Y; Malfertheiner P
J Clin Gastroenterol; 2021 May-Jun 01; 55(5):400-410. PubMed ID: 32398629
[TBL] [Abstract][Full Text] [Related]
12. Pooled Phase 2 and 3 Efficacy and Safety Data on Budesonide Oral Suspension in Adolescents with Eosinophilic Esophagitis.
Mukkada VA; Gupta SK; Gold BD; Dellon ES; Collins MH; Katzka DA; Falk GW; Williams J; Zhang W; Boules M; Hirano I; Desai NK
J Pediatr Gastroenterol Nutr; 2023 Dec; 77(6):760-768. PubMed ID: 37718471
[TBL] [Abstract][Full Text] [Related]
13. Budesonide Orodispersible Tablets Maintain Remission in a Randomized, Placebo-Controlled Trial of Patients With Eosinophilic Esophagitis.
Straumann A; Lucendo AJ; Miehlke S; Vieth M; Schlag C; Biedermann L; Vaquero CS; Ciriza de Los Rios C; Schmoecker C; Madisch A; Hruz P; Hayat J; von Arnim U; Bredenoord AJ; Schubert S; Mueller R; Greinwald R; Schoepfer A; Attwood S;
Gastroenterology; 2020 Nov; 159(5):1672-1685.e5. PubMed ID: 32721437
[TBL] [Abstract][Full Text] [Related]
14. Safety and Efficacy of Budesonide Oral Suspension Maintenance Therapy in Patients With Eosinophilic Esophagitis.
Dellon ES; Katzka DA; Collins MH; Gupta SK; Lan L; Williams J; Hirano I
Clin Gastroenterol Hepatol; 2019 Mar; 17(4):666-673.e8. PubMed ID: 29902649
[TBL] [Abstract][Full Text] [Related]
15. Swallowed topical corticosteroids for eosinophilic esophagitis: Utilization and real-world efficacy from the EoE CONNECT registry.
Laserna-Mendieta EJ; Navarro P; Casabona-Francés S; Savarino EV; Amorena E; Pérez-Martínez I; Guagnozzi D; Blas-Jhon L; Betoré E; Guardiola-Arévalo A; Pellegatta G; Krarup AL; Perello A; Barrio J; Gutiérrez-Junquera C; Teruel Sánchez-Vegazo C; Fernández-Fernández S; Naves JE; Oliva S; Rodríguez-Oballe JA; Carrión S; Espina S; Llorente Barrio M; Masiques-Mas ML; Dainese R; Feo-Ortega S; Martín-Dominguez V; Fernández-Pacheco J; Pérez-Fernández MT; Ghisa M; Maniero D; Nantes-Castillejo Ó; Nicolay-Maneru J; Suárez A; Maray I; Llerena-Castro R; Ortega-Larrodé A; Alcedo J; Granja Navacerrada A; Racca F; Santander C; Arias Á; Lucendo AJ;
United European Gastroenterol J; 2024 Jun; 12(5):585-595. PubMed ID: 38284792
[TBL] [Abstract][Full Text] [Related]
16. Budesonide Oral Suspension Significantly Improves Eosinophilic Esophagitis Histology Scoring System Results: Analyses From a 12-Week, Phase 2, Randomized, Placebo-controlled Trial.
Collins MH; Dellon ES; Katzka DA; Hirano I; Williams J; Lan L
Am J Surg Pathol; 2019 Nov; 43(11):1501-1509. PubMed ID: 31498177
[TBL] [Abstract][Full Text] [Related]
17. Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitis.
Straumann A; Conus S; Degen L; Frei C; Bussmann C; Beglinger C; Schoepfer A; Simon HU
Clin Gastroenterol Hepatol; 2011 May; 9(5):400-9.e1. PubMed ID: 21277394
[TBL] [Abstract][Full Text] [Related]
18. Budesonide Oral Suspension Improves Symptomatic, Endoscopic, and Histologic Parameters Compared With Placebo in Patients With Eosinophilic Esophagitis.
Dellon ES; Katzka DA; Collins MH; Hamdani M; Gupta SK; Hirano I;
Gastroenterology; 2017 Mar; 152(4):776-786.e5. PubMed ID: 27889574
[TBL] [Abstract][Full Text] [Related]
19. Strategies for Medical Management of Pediatric Eosinophilic Esophagitis.
Chawla N; Deshmukh M; Sharma A; Patole S
J Pediatr Gastroenterol Nutr; 2016 Dec; 63(6):e152-e157. PubMed ID: 27306106
[TBL] [Abstract][Full Text] [Related]
20. Novel corticosteroid formulations in the treatment of eosinophilic esophagitis: what is the evidence?
Walgraeve S; Vanuytsel T
Acta Gastroenterol Belg; 2023; 86(3):437-448. PubMed ID: 37814560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]